19:22
2026-07-20
runtimewire.com
artificial-intelligence
Tempus AI to Acquire Personalis for $1.5 Billion, Expanding Oncology Portfolio
Tempus AI Inc. announced on Monday its intent to acquire Personalis Inc. for approximately $1.5 billion, a deal aimed at integrating Personalis' cancer testing capabilities into Tempus' AI-enabled pre…